- Same Thing
- Side Effects
- What Is
- Drug Interactions
Are Ultomiris and Soliris the Same Thing?
Both Ultomiris and Soliris may interact with other drugs.
What Are Possible Side Effects of Ultomiris?
Common side effects of Ultomiris include:
What Are Possible Side Effects of Soliris?
Common side effects of Soliris include:
- muscle pain,
- back pain, or
- cold symptoms such as stuffy nose, sneezing, or sore throat.
Tell your doctor if you have serious side effects of Soliris including:
What Is Ultomiris?
Ultomiris (ravulizumab-cwvz) is a complement inhibitor indicated for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH).
What Is Soliris?
Soliris (eculizumab) is a monoclonal antibody that binds to proteins in the blood that can destroy red blood cells in people with a genetic condition that affects the natural defenses of red blood cells used to prevent the breakdown of red blood cells in people with paroxysmal nocturnal hemoglobinemia (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS).
What Drugs Interact With Ultomiris?
Ultomiris may interact with other drugs. Tell your doctor all medications and supplements you use.
What Drugs Interact With Soliris?
Other drugs may interact with Soliris. Tell your doctor all prescription and over-the-counter medications and supplements you use. During pregnancy, Soliris should be used only when prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.
How Should Ultomiris be Taken?
The recommended dosing regimen of Ultomiris for adult patients with PNH consists of a loading dose followed by maintenance dosing, administered by intravenous infusion. Doses are administered based on the patient's body weight.
How Should Soliris be Taken?
The Soliris therapy dosing regimen to treat PNH in adults consists of: 600 mg weekly for the first 4 weeks, followed by 900 mg for the fifth dose 1 week later, then 900 mg every 2 weeks thereafter. The dosing regimen to treat aHUS in adults consists of: 900 mg weekly for the first 4 weeks, followed by 1200 mg for the fifth dose 1 week later, then 1200 mg every 2 weeks thereafter.
All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).
Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.
Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.
The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.
As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.
Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.
If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.
You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.
Alexion. Soliris Product Information.